文献速递腹部技术与安全CT

应用平衡对比CT测量系统性淀粉样轻链淀粉样变患者肝脏与脾脏细胞外容积

Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

研究纳入26例系统性AL淀粉样变患者,采用平衡对比增强CT测量肝脾细胞外容积(ECV),并以血清淀粉样P成分(SAP)显像分级为参照。结果显示SAP 1-3级淀粉样沉积器官的脾、肝ECV均值分别为0.430、0.375,显著高于健康组织的0.304、0.269(p<0.0005),且ECV与SAP分级在肝(r=0.758)和脾(r=0.867)均呈正相关。结论认为平衡对比CT可显示肝脾ECV升高,且与淀粉样病变负荷相关。

要点

  • SAP 1-3级淀粉样沉积脾ECV均值0.430、肝0.375,高于健康组织脾0.304、肝0.269(p<0.0005)。
  • ECV随淀粉样负荷增加而升高,与SAP分级肝r=0.758、脾r=0.867呈正相关。
  • 平衡对比CT可测量肝脾ECV,作为反映器官淀粉样负荷的影像指标。

核心结论

  • 在系统性AL淀粉样变患者中,平衡对比CT可显示脾和肝ECV升高,且ECV与淀粉样病变负荷相关。

研究设计与样本

  • 研究纳入26例系统性AL淀粉样变患者,行平衡对比增强CT测量肝、脾ECV,并以血清淀粉样P成分(SAP)显像对肝、脾受累进行分级作为参照。

诊断标准与关键数值

  • SAP 1-3级淀粉样沉积器官脾ECV均值0.430、肝0.375,健康组织脾0.304、肝0.269,组间差异p<0.0005。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate equilibrium contrast-enhanced CT (EQ-CT) measurement of extracellular volume fraction (ECV) in patients with systemic amyloid light-chain (AL) amyloidosis, testing the hypothesis that ECV becomes elevated in the liver and spleen and ECV correlates with other estimates of organ amyloid burden.

METHODS: 26 patients with AL amyloidosis underwent EQ-CT, and ECV was measured in the liver and spleen. Patients also underwent serum amyloid P (SAP) component scintigraphy with grading of liver and spleen involvement. Mann-Whitney U test was used to test for a difference between patients with amyloid deposition (SAP grade 1-3) and those without (SAP grade 0). Variation in ECV across SAP grades was assessed using the Kruskal-Wallis test and association between ECV and SAP grades with Spearman correlation.

RESULTS: Mean ECV in the spleen and liver was significantly greater (p < 0.0005) in amyloidotic organs (SAP grade 1-3) [spleen, liver: 0.430, 0.375] compared with healthy tissues [spleen, liver: 0.304, 0.269]. ECV increased with increasing amyloid burden, showing positive correlation with SAP grade in both the liver (r = 0.758) and spleen (r = 0.867).

CONCLUSION: In patients with systemic AL amyloidosis, EQ-CT can demonstrate increased spleen and liver ECV, which is associated with amyloid disease burden.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yeung J, Sivarajan S, Treibel TA, et al. Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT. Abdom Radiol (NY). 2017. PMID: 28567484. doi:10.1007/s00261-017-1194-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。